These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 30556040)

  • 1. Diet-Induced Dysbiosis and Genetic Background Synergize With Cystic Fibrosis Transmembrane Conductance Regulator Deficiency to Promote Cholangiopathy in Mice.
    Debray D; El Mourabit H; Merabtene F; Brot L; Ulveling D; Chrétien Y; Rainteau D; Moszer I; Wendum D; Sokol H; Housset C
    Hepatol Commun; 2018 Dec; 2(12):1533-1549. PubMed ID: 30556040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prominent role of gut dysbiosis in the pathogenesis of cystic fibrosis-related liver disease in mice.
    Bertolini A; Nguyen M; Zehra SA; Taleb SA; Bauer-Pisani T; Palm N; Strazzabosco M; Fiorotto R
    J Hepatol; 2024 Sep; 81(3):429-440. PubMed ID: 38554847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fecal dysbiosis and inflammation in intestinal-specific Cftr knockout mice on regimens preventing intestinal obstruction.
    Young SM; Woode RA; Williams EC; Ericsson AC; Clarke LL
    Physiol Genomics; 2024 Mar; 56(3):247-264. PubMed ID: 38073491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defective FXR-FGF15 signaling and bile acid homeostasis in cystic fibrosis mice can be restored by the laxative polyethylene glycol.
    Bertolini A; van de Peppel IP; Doktorova-Demmin M; Bodewes FAJA; de Jonge H; Bijvelds M; Verkade HJ; Jonker JW
    Am J Physiol Gastrointest Liver Physiol; 2019 Mar; 316(3):G404-G411. PubMed ID: 30653340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristic multiorgan pathology of cystic fibrosis in a long-living cystic fibrosis transmembrane regulator knockout murine model.
    Durie PR; Kent G; Phillips MJ; Ackerley CA
    Am J Pathol; 2004 Apr; 164(4):1481-93. PubMed ID: 15039235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Defects in gallbladder emptying and bile Acid homeostasis in mice with cystic fibrosis transmembrane conductance regulator deficiencies.
    Debray D; Rainteau D; Barbu V; Rouahi M; El Mourabit H; Lerondel S; Rey C; Humbert L; Wendum D; Cottart CH; Dawson P; Chignard N; Housset C
    Gastroenterology; 2012 Jun; 142(7):1581-91.e6. PubMed ID: 22370478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term docosahexaenoic acid therapy in a congenic murine model of cystic fibrosis.
    Beharry S; Ackerley C; Corey M; Kent G; Heng YM; Christensen H; Luk C; Yantiss RK; Nasser IA; Zaman M; Freedman SD; Durie PR
    Am J Physiol Gastrointest Liver Physiol; 2007 Mar; 292(3):G839-48. PubMed ID: 17095751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cystic fibrosis mouse model-dependent intestinal structure and gut microbiome.
    Bazett M; Honeyman L; Stefanov AN; Pope CE; Hoffman LR; Haston CK
    Mamm Genome; 2015 Jun; 26(5-6):222-34. PubMed ID: 25721416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential genetic modifiers of the cystic fibrosis intestinal inflammatory phenotype on mouse chromosomes 1, 9, and 10.
    Norkina O; De Lisle RC
    BMC Genet; 2005 May; 6():29. PubMed ID: 15921521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered intestinal bile salt biotransformation in a cystic fibrosis (Cftr-/-) mouse model with hepato-biliary pathology.
    Bodewes FA; van der Wulp MY; Beharry S; Doktorova M; Havinga R; Boverhof R; James Phillips M; Durie PR; Verkade HJ
    J Cyst Fibros; 2015 Jul; 14(4):440-6. PubMed ID: 25633479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cystic Fibrosis-Related Gut Dysbiosis: A Systematic Review.
    Caley LR; White H; de Goffau MC; Floto RA; Parkhill J; Marsland B; Peckham DG
    Dig Dis Sci; 2023 May; 68(5):1797-1814. PubMed ID: 36600119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fecal Dysbiosis and Inflammation in Intestinal-Specific Cftr Knockout Mice on Regimens Preventing Intestinal Obstruction.
    Young SM; Woode RA; Williams E; Ericsson A; Clarke LL
    bioRxiv; 2023 Jul; ():. PubMed ID: 37546931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Iron Homeostasis and Inflammatory Status in Mice Deficient for the Cystic Fibrosis Transmembrane Regulator.
    Deschemin JC; Allouche S; Brouillard F; Vaulont S
    PLoS One; 2015; 10(12):e0145685. PubMed ID: 26709821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ileal smooth muscle dysfunction and remodeling in cystic fibrosis.
    Risse PA; Kachmar L; Matusovsky OS; Novali M; Gil FR; Javeshghani S; Keary R; Haston CK; Michoud MC; Martin JG; Lauzon AM
    Am J Physiol Gastrointest Liver Physiol; 2012 Jul; 303(1):G1-8. PubMed ID: 22538405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of intestinal and liver features in cystic fibrosis mice by the osmotic laxative polyethylene glycol.
    Bertolini A; Bloks VW; Wilmink M; Bos E; van de Peppel IP; Eilers R; Prins S; Thomas R; de Bruin A; Verkade H; Jonker JW
    J Cyst Fibros; 2024 May; 23(3):461-473. PubMed ID: 37775443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gut microbiota signatures in cystic fibrosis: Loss of host CFTR function drives the microbiota enterophenotype.
    Vernocchi P; Del Chierico F; Russo A; Majo F; Rossitto M; Valerio M; Casadei L; La Storia A; De Filippis F; Rizzo C; Manetti C; Paci P; Ercolini D; Marini F; Fiscarelli EV; Dallapiccola B; Lucidi V; Miccheli A; Putignani L
    PLoS One; 2018; 13(12):e0208171. PubMed ID: 30521551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ursodeoxycholate modulates bile flow and bile salt pool independently from the cystic fibrosis transmembrane regulator (Cftr) in mice.
    Bodewes FA; Wouthuyzen-Bakker M; Bijvelds MJ; Havinga R; de Jonge HR; Verkade HJ
    Am J Physiol Gastrointest Liver Physiol; 2012 May; 302(9):G1035-42. PubMed ID: 22301109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lung pathology in response to repeated exposure to Staphylococcus aureus in congenic residual function cystic fibrosis mice does not increase in response to decreased CFTR levels or increased bacterial load.
    Davidson DJ; Webb S; Teague P; Govan JR; Dorin JR
    Pathobiology; 2004; 71(3):152-8. PubMed ID: 15051928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cystic fibrosis transmembrane conductance regulator controls biliary epithelial inflammation and permeability by regulating Src tyrosine kinase activity.
    Fiorotto R; Villani A; Kourtidis A; Scirpo R; Amenduni M; Geibel PJ; Cadamuro M; Spirli C; Anastasiadis PZ; Strazzabosco M
    Hepatology; 2016 Dec; 64(6):2118-2134. PubMed ID: 27629435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cystic fibrosis transmembrane conductance regulator deficiency exacerbates islet cell dysfunction after beta-cell injury.
    Stalvey MS; Muller C; Schatz DA; Wasserfall CH; Campbell-Thompson ML; Theriaque DW; Flotte TR; Atkinson MA
    Diabetes; 2006 Jul; 55(7):1939-45. PubMed ID: 16804061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.